tiprankstipranks
NeuroBo Pharmaceuticals Announces Key Leadership Appointment
PremiumCompany AnnouncementsNeuroBo Pharmaceuticals Announces Key Leadership Appointment
2M ago
NeuroBo Pharmaceuticals receives first site IRB approval for obesity trial
PremiumThe Fly
NeuroBo Pharmaceuticals receives first site IRB approval for obesity trial
2M ago
NeuroBo Pharmaceuticals Signals Updates in Corporate Outlook
PremiumCompany Announcements
NeuroBo Pharmaceuticals Signals Updates in Corporate Outlook
2M ago
NeuroBo submits IND application to FDA for Phase 1 trial of DA-1726
PremiumThe FlyNeuroBo submits IND application to FDA for Phase 1 trial of DA-1726
4M ago
NeuroBo Pharmaceuticals trading halted, news pending
PremiumThe Fly
NeuroBo Pharmaceuticals trading halted, news pending
4M ago
NeuroBo Pharmaceuticals announces 1-for-8 reverse stock split
PremiumThe Fly
NeuroBo Pharmaceuticals announces 1-for-8 reverse stock split
4M ago
NeuroBo Pharmaceuticals: First site IRB approval for Phase 2a trial of DA-1241
PremiumThe FlyNeuroBo Pharmaceuticals: First site IRB approval for Phase 2a trial of DA-1241
9M ago
NeuroBo Pharma enters term sheet with MThera Pharma to out-license NB-01
PremiumThe Fly
NeuroBo Pharma enters term sheet with MThera Pharma to out-license NB-01
9M ago
NeuroBo Pharmaceuticals’ DA-1726 shows weight loss efficacy in preclinical tests
PremiumThe Fly
NeuroBo Pharmaceuticals’ DA-1726 shows weight loss efficacy in preclinical tests
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100